This report contains market size and forecasts of Choroidal Neovascularization in global, including the following market information:
Global Choroidal Neovascularization Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Choroidal Neovascularization Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Choroidal Neovascularization companies in 2020 (%)
The global Choroidal Neovascularization market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Choroidal Neovascularization manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Choroidal Neovascularization Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Choroidal Neovascularization Market Segment Percentages, By Type, 2020 (%)
Intravenous
Intravitreal

Global Choroidal Neovascularization Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Choroidal Neovascularization Market Segment Percentages, By Application, 2020 (%)
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments

Global Choroidal Neovascularization Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Choroidal Neovascularization Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Choroidal Neovascularization revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Choroidal Neovascularization revenues share in global market, 2020 (%)
Key companies Choroidal Neovascularization sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Choroidal Neovascularization sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc